Why has the picture of vaccination changed ?:India, which used to import corona vaccine from all over the world, is now forced to import it.
India also needs to speed up imports of foreign vaccines.
Amid another wave of corona rampant in the country on a daily basis, there are reports of vaccine shortages in several states. The situation is that India has also allowed all foreign vaccines approved by the WHO to be administered to the people there, whether or not there has been a clinical trial. Why such a situation? Where did the Indian government go wrong? Why is this bad news not only for India but also for the world? Let's understand ...
What happened to the rapidly changing situation?
India, which had made it clear to foreign giants like Pfizer that their vaccines would be taken only when they were tried here, now had to abruptly relax the rules to fast-track vaccine imports. Starting this month, it will begin importing Russia's Sputnik V vaccine.
Corona 'tsunami'
in India India, the world's second most populous country, needs a large amount of vaccine. No one thought the second wave of Corona transition would be so ferocious. On Thursday, for the first time in India, the number of new cases arriving in a single day crossed 2 lakh. The Corona tsunami put great pressure on India to quickly vaccinate its large population but now there is a shortage of vaccines.
Lack of raw material is one of the major reasons for the
supply of vaccines and sources said that there are a number of factors that are contributing to the shortage of vaccines in India. One big reason is the lack of raw materials. The world's largest vaccine maker, Pune's Serum Institute of India, wants to increase its manufacturing capacity. The United States has banned the export of critical equipment and raw materials associated with vaccine manufacturing.
On Friday, Adar Poonawala, CEO of the Serum Institute of India, took to Twitter to urge the US President to start supplying raw materials for the vaccine. SII currently has the capacity to make 70 million vaccine doses a month, which it wants to increase to 100 million, but production is being delayed due to supply of raw material.
Lack of investment
Capital is also needed to increase vaccine production capacity. The Serum Institute of India (SII) has demanded Rs 3,000 crore from the Government of India for rapid increase in productivity, but no action has been taken by the government so far.
Delayed the final deal on the price from the Government of India
, the Indian government has delayed a determined price per dose of vaccine serum kovisilda. The government was able to finalize the price about two weeks after the vaccine was approved for emergency use in India. The debate lasted for months. The Serum Institute had started mass production of the vaccine in October. It so happened that at one point he had stockpiled 50 million doses of the vaccine, leaving no space to keep the vaccine. In January, Serum CEO Poonawala told Reuters he had to stop packing when more than 50 million doses of the vaccine were available. If he had more packing he would have had to store the vaccine in his own home. If the government had made a purchase deal with the serum in the meantime, the company would not have had to stop production at its full capacity.
Why is it a matter of concern not only for India but also for the world?
The shortage of corona vaccine in Asia's pharma powerhouse India is bad news not only for India itself, but also for the world. This will affect the vaccination campaign in more than 60 poor countries around the world. Most of these are African countries. All these countries are largely dependent on India for vaccines. The COVAX program, run with the support of the World Health Organization, and the Gavi vaccine Alliance work towards the goal of making the vaccine available to countries around the world. For this it depends on India. Vaccine shortages in India alone could worsen the situation.
India's own priority needs
, according to an official familiar with the Strategy's vaccine, like now available doses will be used in the country, because of the emergency situation. He said there was no commitment with other countries. This is also clear in the statistics of the Ministry of External Affairs. India exported about 64 million doses of the vaccine between January and March, but only 1.2 million doses have been exported so far this month.
India aims to vaccinate 400 million people by August India initially aims to vaccinate its nearly 300 million high-risk populations by August. This is about one-fifth of India's total population, but now the government has raised the target to 400 million. In order to achieve this, not only the production of domestic vaccines has to be increased rapidly, but also the import of foreign vaccines has to be accelerated.
No comments:
Post a Comment